ctrl K

AI Score

Unlock

LAVA Therapeutics N.V. (LVTX)

AI Score

Unlock

1.32

-0.03 (-2.22%)

At close: Mar 13, 2025, 3:49 PM

1.29

-2.54%

After-hours: Mar 13, 2025, 04:57 PM EDT

LAVA Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	6.77M	19.39M	5.35M	3.75M	n/a
Cost of Revenue	3.48M	n/a	n/a	15.7M	8.35M
Gross Profit	3.29M	19.39M	5.35M	-11.95M	-8.35M
Operating Income	-43.25M	-34.84M	-43.61M	-14.67M	-9.58M
Interest Income	2.97M	257K	625K	342K	86K
Pretax Income	-41.7M	-31.66M	-42.2M	-15.88M	-9.69M
Net Income	-41.97M	-31.91M	-42.35M	-15.93M	-9.69M
Selling & General & Admin	12.73M	14.12M	12.02M	2.72M	1.24M
Research & Development	33.81M	40.1M	36.95M	15.7M	8.35M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	46.54M	51.31M	46.92M	3.59M	1.25M
Interest Expense	n/a	n/a	625K	342K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	50.02M	51.31M	46.92M	19.29M	9.6M
Income Tax	279K	249K	157K	43K	n/a
Shares Outstanding (Basic)	26.73M	25.92M	19.76M	25.35M	18.41M
Shares Outstanding (Diluted)	26.73M	25.92M	19.76M	25.35M	18.41M
EPS (Basic)	-1.57	-1.23	-2.14	-39.9	-21.65
EPS (Diluted)	-1.57	-1.23	-2.14	-39.9	-21.65
EBITDA	-40.42M	-30.88M	-41.02M	-14.65M	-9.48M
Depreciation & Amortization	1.28M	504K	331K	213K	99K